Form 4: Medtronic Director Denise M. O'Leary Reports Stock Transaction

Director Denise M. O'Leary reports a transaction involving Medtronic plc ordinary shares for tax obligations.

Summary

• On May 1, 2024, Denise M. O'Leary, a director of Medtronic plc, had 192 ordinary shares withheld to cover tax obligations.
• The shares were withheld at a price of $80.89 per share.
• Following the transaction, O'Leary directly owns 77,057 ordinary shares of Medtronic plc.

Sentiment

Score: 7

Explanation: The sentiment is neutral as it reports a routine transaction related to tax obligations. It's a standard procedure and doesn't indicate any significant positive or negative outlook for the company.

Industry Context

Form 4 filings are standard practice for reporting transactions by company insiders, providing transparency to the market.

Comparison to Industry Standards

• Directors and officers of publicly traded companies like Medtronic are required to report changes in their beneficial ownership of the company's securities.
• These filings are comparable to those of executives at similar medical device companies such as Johnson & Johnson, Abbott Laboratories, and Boston Scientific, where insider transactions are routinely disclosed to maintain market transparency.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a routine tax-related share withholding.

Key Dates